Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study-Reference-Cited by-同舟云学术

Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study

Published:2021-10-07 Issue:11 Volume:34 Page:2305-2316
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Douwes Rianne M.¹,Vinke Joanna Sophia J.¹,Gomes‐Neto António W.¹,Ayerdem Gizem¹,Hassel Gaston¹,Berger Stefan P.¹,Touw Daan J.²,Blokzijl Hans³,Bakker Stephan J. L.¹,Borst Martin H.¹,Eisenga Michele F.¹

Affiliation:

1. Department of Internal Medicine Division of Nephrology University of Groningen University Medical Center Groningen Groningen The Netherlands

2. Department of Clinical Pharmacy and Pharmacology University of Groningen University Medical Center Groningen Groningen The Netherlands

3. Department of Gastroenterology and Hepatology University of Groningen University Medical Center Groningen Groningen The Netherlands

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.14110

Reference32 articles.

1. Routine prophylaxis with proton pump inhibitors and post-transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal

2. Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients

3. Iron deficiency, anemia, and mortality in renal transplant recipients

4. Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH

5. Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the TransplantLines Biobank and Cohort Study;American Journal of Kidney Diseases;2023-08

2. Pump proton inhibitors display anti‐tumour potential in glioma;Cell Proliferation;2022-08-12